Pharmaconutrition for the obese, critically ill patient (Q37924442)

25 August 2017

1 reference

title

Pharmaconutrition for the obese, critically ill patient (English)

1 reference

25 August 2017

0 references

1 reference

Ryan T Hurt

1

1 reference

25 August 2017

Thomas H Frazier

series ordinal

2

1 reference

25 August 2017

Stephen A McClave

series ordinal

3

1 reference

25 August 2017

Matt C Cave

series ordinal

4

1 reference

25 August 2017

language of work or name

1 reference

1 September 2011

1 reference

Journal of Parenteral and Enteral Nutrition

25 August 2017

1 reference

25 August 2017

35

1 reference

25 August 2017

5 Suppl

1 reference

25 August 2017

60S-72S

1 reference

Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature

25 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Immunonutrition in the intensive care unit. A systematic review and consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Obesity as a risk factor for nosocomial infections in trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Obesity is an independent risk factor of mortality in severely injured blunt trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Differences in outcome between obese and nonobese patients following severe blunt trauma are not consistent with an early inflammatory genomic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Obesity, inflammation, and the potential application of pharmaconutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Obesity-induced hepatic hypoperfusion primes for hepatic dysfunction after resuscitated hemorrhagic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Critical care of the obese and bariatric surgical patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Obesity and inflammation: should the principles of immunonutrition be applied to this disease process?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Immune-enhancing diet and cytokine expression during chronic sepsis: an immune-enhancing diet containing L-arginine, fish oil, and RNA fragments promotes intestinal cytokine expression during chronic sepsis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Enteral glutamine supplementation impairs intestinal blood flow in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Immune-enhancing enteral diet increases blood flow and proinflammatory cytokines in the rat ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

The effects of hydroxycinnamic acid derivatives on adiponectin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Synergistic anti-inflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: docosahexaenoic acid or eicosapentaenoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Sulforaphane suppresses LPS-induced inflammation in primary rat microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Inhibition of LXRα-dependent steatosis and oxidative injury by liquiritigenin, a licorice flavonoid, as mediated with Nrf2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Ajoene, a stable garlic by-product, has an antioxidant effect through Nrf2-mediated glutamate-cysteine ligase induction in HepG2 cells and primary hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Laboratory, epidemiological, and human intervention studies show that tea (Camellia sinensis) may be useful in the prevention of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Beneficial effects of green tea: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARgamma2 and C/EBPalpha in 3T3-L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Anti-obesity effects of green tea: from bedside to bench.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Anti-obesity actions of green tea: possible involvements in modulation of the glucose uptake system and suppression of the adipogenesis-related transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Effects of epigallocatechin gallate on regulatory T cell number and function in obese v. lean volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Green tea EGCG suppresses T cell proliferation through impairment of IL-2/IL-2 receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Hepatotoxicity from green tea: a review of the literature and two unpublished cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Immunonutrition in critically ill patients: a systematic review and analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

"Sick fat," metabolic disease, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

The effect of prescription omega-3 fatty acids on body weight after 8 to 16 weeks of treatment for very high triglyceride levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Effects of docosahexaenoic acid in an experimental rat model of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

The role of fatty acids in the development and progression of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Beef fat prevents alcoholic liver disease in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Relationship between fatty liver and subsequent development of necrosis, inflammation and fibrosis in experimental alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Arginine metabolism and nutrition in growth, health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

The effect of consecutively larger doses of L-arginine on hepatic microcirculation and tissue oxygenation in hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

The role of nitric oxide in the modulation of hepatic microcirculation and tissue oxygenation in an experimental model of hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Dietary L-arginine supplementation reduces white fat gain and enhances skeletal muscle and brown fat masses in diet-induced obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

The genetic backbone modulates the phenotype of hepatitis B surface antigen mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Different central opioid receptor subtype antagonists modify maltose dextrin and deprivation-induced water intake in sham feeding and sham drinking rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

The effect of gastric loads of sugars and amino acids on milk intake of suckling pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

L-citrulline-malate influence over branched chain amino acid utilization during exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Protein metabolic roles in treatment of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Successful weight loss maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Regulation of food intake through hypothalamic signaling networks involving mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

The leucine content of a complete meal directs peak activation but not duration of skeletal muscle protein synthesis and mammalian target of rapamycin signaling in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Amino acid ingestion improves muscle protein synthesis in the young and elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Leptin in energy balance and reward: two faces of the same coin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Hypothalamic mTOR signaling regulates food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Metabolic effects of high-protein diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Dose-dependent satiating effect of whey relative to casein or soy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Hypocaloric enteral tube feeding in critically ill obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

The role of the gut microbiota in energy metabolism and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

The role of zinc deficiency in alcohol-induced intestinal barrier dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

21 January 2018

The safety of probiotics

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Bacterial, SCFA and gas profiles of a range of food ingredients following in vitro fermentation by human colonic microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Beneficial effects versus toxicity of medium-chain triacylglycerols in rats with NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

Changes in intestinal bifidobacteria levels are associated with the inflammatory response in magnesium-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111413775

21 January 2018

Identifiers

DOI

10.1177/0148607111413775

1 reference

25 August 2017

1 reference